Subsequent Events

6 Months Ended

Nov. 30, 2016

Subsequent Events [Abstract]

Subsequent Events [Text Block]

Note 6: Subsequent Events

     Subsequent to November 30, 2016 options to purchase 157,625 shares of the Company’s common stock were exercised after the end of the quarter ended November 30, 2016 at purchase prices ranging from $0.43 to $0.71 per share. Proceeds to the Company totaled approximately $68,500.

     In December 2016 the Company entered into a Clinical Trial Agreement with a major U.S. university to start the clinical trials for a gastrointestinal product that the Company is developing.